MLH1 and cancer: Sporadic cancers associated with hyper-methylation of the MutL homolog-1 (MLH1) promoter account for nearly 30 % of MSI CRCs, while others involve a hereditary MMR defect known as Hereditary Non-Polyposis Colorectal Cancer (HNPCC) or Lynch syndrome [18].